l 670596 has been researched along with ridogrel in 1 studies
| Studies (l 670596) | Trials (l 670596) | Recent Studies (post-2010) (l 670596) | Studies (ridogrel) | Trials (ridogrel) | Recent Studies (post-2010) (ridogrel) |
|---|---|---|---|---|---|
| 21 | 0 | 0 | 90 | 10 | 1 |
| Protein | Taxonomy | l 670596 (IC50) | ridogrel (IC50) |
|---|---|---|---|
| Thromboxane A2 receptor | Homo sapiens (human) | 2.48 | |
| Thromboxane-A synthase | Homo sapiens (human) | 0.0062 | |
| Thromboxane-A synthase | Rattus norvegicus (Norway rat) | 0.006 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Colombo, M; Dho, L; Pierucci, L; Rosa, B; Salvati, P; Ukmar, G; Vaghi, F; Volpi, D | 1 |
1 other study(ies) available for l 670596 and ridogrel
| Article | Year |
|---|---|
Pharmacological characterization of FCE 27262, a combined thromboxane synthase inhibitor and PGH2/TXA2 receptor antagonist.
Topics: Animals; Aorta; Aspirin; Blood Platelets; Carbazoles; Coronary Thrombosis; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Female; Fibrinolytic Agents; Guinea Pigs; Humans; Imidazoles; Male; Pentanoic Acids; Platelet Aggregation; Pyridines; Rabbits; Rats; Receptors, Prostaglandin; Receptors, Thromboxane; Receptors, Thromboxane A2, Prostaglandin H2; Thromboxane-A Synthase | 1993 |